LEADER 01691nam  2200445Ia 450 
001 9910698896903321
005 20090504143659.0
035   $a(CKB)5470000002396892
035   $a(OCoLC)320121326
035   $a(EXLCZ)995470000002396892
100   $a20090504d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eadequate and appropriate donor screening for hepatitis b : hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2007]
215   $ai, 4 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 5, 2009).
300   $a"November 2007".
320   $aIncludes bibliographical references (page 4).
517   $aGuidance for industry 
606   $aBlood donors
606   $aBlood plasma$xTesting
606   $aLeucocytes$xTesting
606   $aHepatitis associated antigen
606   $aHepatitis B$zUnited States$xPrevention
615  0$aBlood donors.
615  0$aBlood plasma$xTesting.
615  0$aLeucocytes$xTesting.
615  0$aHepatitis associated antigen.
615  0$aHepatitis B$xPrevention.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698896903321
996   $aGuidance for industry$93434577
997   $aUNINA